Compare Cigna Corp (CI) vs H2O America (HTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs H2O America — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while H2O America trades at $62.24 (market cap $2.56B). The key difference: Cigna Corp is far larger — about 28.7× H2O America's market cap, and H2O America pays the higher dividend (2.87%). Which is the better fit depends on your goals.
| CI | HTO | |
|---|---|---|
Market Cap | $73.56B | $2.56B |
Sector | Health | Technology |
52-Week High | $311.00 | $65.43 |
52-Week Low | $244.41 | $44.44 |
Enterprise Value | $98.27B | $4.35B |
Dividend Yield | 2.24% | 2.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
HTO trades at $62.66, up 1.42% with a bullish technical signal supported by moving averages. The company reported mixed earnings with Q2 2026 EPS beating expectations at $0.72 versus $0.699, but Q4 2025 missed. Fundamentals show strong gross margins at 56.91% and revenue growth to $829M projected for 2026. Recent news highlights institutional acquisitions and transformative Texas water utility expansion via the Quadvest deal.
Outlook remains positive with analyst consensus Buy rating (83%) and $69.50 price target offering ~11% upside. Key risks include execution challenges from acquisitions and EPS dilution from recent equity issuance. The dividend yield appears sustainable given cash flow trends, supporting income investors amid steady utility growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About H2O America
H2O America is a utility company that provides essential water and wastewater services, primarily in the United States. The company operates a network of regulated water and wastewater systems, focusing on responsible resource management and high-quality service delivery. HTO aims to expand its operational footprint through acquisitions and internal growth, serving residential, commercial, and industrial customers.
Read more on HTO →
